These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 16539399)
1. Kinase patent space visualization using chemical replacements. Southall NT; Ajay J Med Chem; 2006 Mar; 49(6):2103-9. PubMed ID: 16539399 [TBL] [Abstract][Full Text] [Related]
2. Predicting key example compounds in competitors' patent applications using structural information alone. Hattori K; Wakabayashi H; Tamaki K J Chem Inf Model; 2008 Jan; 48(1):135-42. PubMed ID: 18177028 [TBL] [Abstract][Full Text] [Related]
3. Biologically relevant chemical space navigator: from patent and structure-activity relationship analysis to library acquisition and design. Rabal O; Oyarzabal J J Chem Inf Model; 2012 Dec; 52(12):3123-37. PubMed ID: 23176522 [TBL] [Abstract][Full Text] [Related]
4. Intuitive patent Markush structure visualization tool for medicinal chemists. Deng W; Berthel SJ; So WV J Chem Inf Model; 2011 Mar; 51(3):511-20. PubMed ID: 21381694 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents. Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745 [TBL] [Abstract][Full Text] [Related]
6. Exploring sets of molecules from patents and relationships to other active compounds in chemical space networks. Kunimoto R; Bajorath J J Comput Aided Mol Des; 2017 Sep; 31(9):779-788. PubMed ID: 28871390 [TBL] [Abstract][Full Text] [Related]
7. In silico identification of bioisosteric functional groups. Ertl P Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854 [TBL] [Abstract][Full Text] [Related]
8. Selective optimization of side activities: another way for drug discovery. Wermuth CG J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318 [No Abstract] [Full Text] [Related]
9. ChemGPS-NP: tuned for navigation in biologically relevant chemical space. Larsson J; Gottfries J; Muresan S; Backlund A J Nat Prod; 2007 May; 70(5):789-94. PubMed ID: 17439280 [TBL] [Abstract][Full Text] [Related]
10. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States. Miller CP; Ullrich JW Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591 [TBL] [Abstract][Full Text] [Related]
11. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds. Tetko IV; Poda GI J Med Chem; 2004 Nov; 47(23):5601-4. PubMed ID: 15509156 [TBL] [Abstract][Full Text] [Related]
13. Rendezvous in chemical space? Comparing the small molecule compound libraries of Bayer and Schering. Schamberger J; Grimm M; Steinmeyer A; Hillisch A Drug Discov Today; 2011 Jul; 16(13-14):636-41. PubMed ID: 21554978 [TBL] [Abstract][Full Text] [Related]
14. Patent holdings of US biotherapeutic companies in major markets. Sebastian TE; Yerram CB; Saberwal G Drug Discov Today; 2009 May; 14(9-10):442-5. PubMed ID: 19429502 [TBL] [Abstract][Full Text] [Related]
18. Extraction and analysis of chemical modification patterns in drug development. Shigemizu D; Araki M; Okuda S; Goto S; Kanehisa M J Chem Inf Model; 2009 Apr; 49(4):1122-9. PubMed ID: 19391632 [TBL] [Abstract][Full Text] [Related]
19. Known drug space as a metric in exploring the boundaries of drug-like chemical space. Mirza A; Desai R; Reynisson J Eur J Med Chem; 2009 Dec; 44(12):5006-11. PubMed ID: 19782440 [TBL] [Abstract][Full Text] [Related]
20. Chemical structure searching: taking it to the next level. Miller K; Poolman R Pharm Pat Anal; 2012 Jul; 1(3):269-74. PubMed ID: 24236840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]